Skip to content

Study · Not a test of the peptide alone · 2025

1 result

Involvement of STAT3 activation in ameliorating all-trans-retinal-induced ferroptosis in photoreceptor-derived 661W cells in vitro.

Chen C, Yang J, Wang H, Lei Y, Diao Y

Experimental eye research11 Feb 2025Cited by 4 (Europe PMC)

PMID39947311 (opens in a new tab)DOI10.1016/j.exer.2025.110280 (opens in a new tab)PepBankPUB-39947311
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Colivelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Colivelin.

  1. 01LabNot a test of Colivelin aloneIn vitro (cells)Efficacy outcome

    In atRAL-exposed mouse photoreceptor cells, colivelin may significantly reduce ferroptosis through ACSL4 and PTGS2 regulation.

    In plain wordsIn cells exposed to atRAL, colivelin may reduce ferroptosis.

    Peptide
    Colivelin
    Outcome
    DecreaseFerroptosis
    Study

    mousen: not reported in source

    atRAL-exposed 661W photoreceptor cells
    Outcome group
    Neuroprotection · Eye

    Source sentences

    Summary
    Additionally, our findings further confirm that STAT3 activator Colivelin may significantly reduce ferroptosis in 661W photoreceptor cells exposed to atRAL by regulating the ACSL4 and PTGS2 gene.
    1 context sentence
    Summary · context
    In this study, we explore the involvement of signal transducer and activator of transcription 3 (STAT3) in the regulation of atRAL-induced 661W photoreceptor cells (mouse-derived photoreceptor cells) ferroptosis.

    In this study, Colivelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Colivelin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.